Open AccessPeripherally restricted cannabinoid type 1 receptor (CB1R) antagonist, AM6545, potentiates stress-induced hypothalamic–pituitary–adrenal axis activation via a non-CB1R mechanism
Author(s) -
CJ Roberts,
Cecilia J. Hillard
Publication year - 2020
Publication title -
endocrine
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1559-0100
pISSN - 1355-008X
DOI - 10.1007/s12020-020-02549-1
Subject(s) - rimonabant , inverse agonist , endocrinology , antagonist , medicine , cannabinoid receptor , cannabinoid , agonist , pharmacology , receptor